Growth Metrics

Bionano Genomics (BNGO) Receivables - Other (2021 - 2025)

Bionano Genomics (BNGO) has disclosed Receivables - Other for 5 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 45.45% to $12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2025, down 45.45% year-over-year, with the annual reading at $12000.0 for FY2025, 45.45% down from the prior year.
  • Receivables - Other hit $12000.0 in Q4 2025 for Bionano Genomics, down from $22000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $474000.0 in Q4 2022 to a low of $12000.0 in Q4 2025.
  • Historically, Receivables - Other has averaged $247400.0 across 5 years, with a median of $342000.0 in 2023.
  • Biggest five-year swings in Receivables - Other: rose 22.48% in 2022 and later plummeted 93.57% in 2024.
  • Year by year, Receivables - Other stood at $387000.0 in 2021, then grew by 22.48% to $474000.0 in 2022, then dropped by 27.85% to $342000.0 in 2023, then tumbled by 93.57% to $22000.0 in 2024, then crashed by 45.45% to $12000.0 in 2025.
  • Business Quant data shows Receivables - Other for BNGO at $12000.0 in Q4 2025, $22000.0 in Q4 2024, and $342000.0 in Q4 2023.